RF
BLTE

Rossby Financial’s Belite Bio BLTE Stock Holding History

Rossby Financial’s Portfolio BLTE Stock Details BLTE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.08K Sell
20
-35
-64% -$5.36K ﹤0.01% 1606
2026
Q1 		$9.2K Buy
55
+42
+323% +$7.06K ﹤0.01% 1287
2025
Q4 		$2.08K Hold
13
– – ﹤0.01% 1361
2025
Q3 		$956 Buy
+13
New +$853 ﹤0.01% 1293

Other funds holding BLTE

DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $44.4B AUM 57.89% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Rossby Financial's BLTE Position: Q2 2026 in Review

Rossby Financial reduced its Belite Bio (BLTE) stake by 64% in Q2 2026, selling an estimated $5.36K and leaving 20 shares worth $3.08K. The position accounts for ﹤0.01% of the portfolio, ranked #1606.

Rossby Financial first reported a position in BLTE in Q3 2025 and has held it in 4 quarters since. The position peaked at $9.2K in Q1 2026. 81 funds tracked by Wall St. Rank hold BLTE as of Q2 2026.

  • Rossby Financial held 20 shares of Belite Bio worth $3.08K as of Q2 2026.
  • Rossby Financial sold 35 Belite Bio shares in Q2 2026, an estimated $5.36K.
  • Belite Bio made up ﹤0.01% of Rossby Financial's portfolio in Q2 2026, its #1606 holding.
  • Rossby Financial first reported a position in Belite Bio in Q3 2025 and has held it in 4 quarters since.
  • Rossby Financial's Belite Bio position peaked at $9.2K in Q1 2026.
  • 81 funds tracked by Wall St. Rank held Belite Bio as of Q2 2026.

Based on Rossby Financial's 13F filing for Q2 2026, filed 4 Aug 2026.